We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
The Greenbrier Companies
GBX
$1.42B
| $4.93M | 0.02% |
114,439
+26,604
| +30% | +$786K |
|
677
Vertex Pharmaceuticals
VRTX
$131B
| $4.93M | 0.02% |
+14,000
| New | +$4.72M |
|
678
Lantheus
LNTH
$6.59B
| $4.9M | 0.02% |
58,435
+52,449
| +876% | +$4.71M |
|
679
BOK Financial
BOKF
$8.85B
| $4.9M | 0.02% |
60,639
-24,221
| -29% | -$2M |
|
680
Gates Industrial Corporation Ltd.
GTES
$7B
| $4.85M | 0.02% |
360,020
+118,868
| +49% | +$1.54M |
|
681
VF Corp
VFC
$5.79B
| $4.85M | 0.02% |
254,102
-320,963
| -56% | -$6.58M |
|
682
iQIYI
IQ
$1.31B
| $4.85M | 0.02% |
908,272
-953,266
| -51% | -$5.36M |
|
683
Sherwin-Williams
SHW
$87.8B
| $4.81M | 0.02% |
18,134
-396,687
| -96% | -$93.4M |
|
684
Oceaneering
OII
$5.11B
| $4.79M | 0.02% |
256,416
-261,311
| -50% | -$4.5M |
|
685
Agnico Eagle Mines
AEM
$91.3B
| $4.78M | 0.02% |
+95,540
| New | +$5.17M |
|
686
Omnicom Group
OMC
$24.2B
| $4.75M | 0.02% |
+49,904
| New | +$4.63M |
|
687
Meritage Homes
MTH
$4.8B
| $4.71M | 0.02% |
66,232
-187,632
| -74% | -$11.8M |
|
688
Ryder
R
$10.1B
| $4.7M | 0.02% |
55,424
+27,359
| +97% | +$2.25M |
|
689
Customers Bancorp
CUBI
$2.82B
| $4.7M | 0.02% |
155,258
-158,872
| -51% | -$3.56M |
|
690
Weibo
WB
$1.88B
| $4.7M | 0.02% |
358,154
+319,785
| +833% | +$5.08M |
|
691
Assurant
AIZ
$13.9B
| $4.69M | 0.02% |
37,284
-99,674
| -73% | -$12.4M |
|
692
Wabtec
WAB
$50.3B
| $4.68M | 0.02% |
42,668
+38,018
| +818% | +$3.77M |
|
693
Bruker
BRKR
$8.83B
| $4.68M | 0.02% |
+63,285
| New | +$4.82M |
|
694
Certara
CERT
$1.24B
| $4.67M | 0.02% |
256,561
+78,742
| +44% | +$1.66M |
|
|
SOVO
695
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $4.66M | 0.02% |
+238,089
| New | +$4.3M |
|
696
Helix Energy Solutions
HLX
$1.49B
| $4.66M | 0.02% |
630,813
+137,207
| +28% | +$976K |
|
697
Remitly
RELY
$5.39B
| $4.65M | 0.02% |
247,207
+139,755
| +130% | +$2.54M |
|
698
Alphatec Holdings
ATEC
$1.51B
| $4.64M | 0.02% |
257,790
+223,814
| +659% | +$3.49M |
|
699
Diageo
DEO
$52.8B
| $4.63M | 0.02% |
26,691
-78,236
| -75% | -$14M |
|
700
Elanco Animal Health
ELAN
$11.2B
| $4.59M | 0.02% |
456,536
-71,459
| -14% | -$663K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.